As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively neutralize the SARS-CoV-2 variant with the D614G substitution and the B.1.1.7 variant, whereas the neutralization of the B.1.351 variant is five-fold reduced. Despite the reduction, 92% of the seronegative vaccinees have a neutralization titre of >20 for the B.1.351 variant indicating some protection. The vaccinees’ neutralization titres exceeded those of recovered non-hospitalized COVID-19 patients. Our work provides evidence that the second dose of the BNT162b2 vaccine induces cross-neutralization of at least some of the circulating SARS-CoV-2 variants. Emerging SARS-CoV-2 variants contain mutations in the spike protein that may affect vaccine efficacy. Here, Jalkanen et al . show, using sera from 180 BNT162b2-vaccinated health care workers, that neutralization of SARS-CoV2 variant B.1.1.7 is not affected, while neutralization of B.1.351 variant is five-fold reduced.
【저자키워드】 antibodies, SARS-CoV-2, RNA vaccines, 【초록키워드】 neutralizing antibody, Efficacy, Vaccine, BNT162b2 vaccine, SARS-CoV2, COVID-19 vaccine, Mutation, Health care, Neutralizing antibodies, B.1.351, neutralization, health care workers, variant, SARS-CoV-2 variant, vaccine efficacy, Spike protein, BNT162b2, B.1.1.7 variant, SARS-CoV-2 variants, protective immunity, B.1.1.7, sera, cross-neutralization, Re-infection, Health care worker, vaccine candidate, COVID-19 patients, BNT162b2 mRNA COVID-19 vaccine, BNT162b2 mRNA, Evidence, reduction, Clinical use, B.1.351 variant, second dose, titre, circulating, vaccine candidates, specific neutralizing antibodies, D614G substitution, circulating SARS-CoV-2 variants, show, seronegative vaccinees, Affect, neutralize, raised, reduced, provide, the spike protein, induce, not affected, exceeded, seronegative vaccinee, the SARS-CoV-2, 【제목키워드】 COVID-19, mRNA vaccine, Antibody Response,